Comparative effects of oral esterified estrogens with and without methyltestosterone on endocrine profiles and dimensions of sexual function in postmenopausal women with hypoactive sexual desire.
about
Testosterone for peri and postmenopausal womenRole of androgens, progestins and tibolone in the treatment of menopausal symptoms: a review of the clinical evidencePostmenopausal syndromeSymptoms in peri- and postmenopausal women in relation to testosterone concentrations: data from The Women's Health in the Lund Area (WHILA) study.Testosterone therapy in women: a review.Pharmacologic treatment options for hypoactive sexual desire disorder.Benefits and risks of testosterone treatment for hypoactive sexual desire disorder in women: a critical review of studies published in the decades preceding and succeeding the advent of phosphodiesterase type 5 inhibitors.Psychopharmacology of male rat sexual behavior: modeling human sexual dysfunctions?Outcome measurement in female sexual dysfunction clinical trials: review and recommendations.The role of androgens in hormone replacement therapy.Progress in female sexual dysfunction.Increasing women's sexual desire: The comparative effectiveness of estrogens and androgens.'Off-label' drug use in sexual medicine treatment.Pharmacologically induced hypogonadism and sexual function in healthy young women and menTestosterone therapy for sexual dysfunction in postmenopausal women.Testosterone and libido in surgically and naturally menopausal women.Therapeutic options for postmenopausal female sexual dysfunction.Testosterone, SHBG and cardiovascular health in postmenopausal women.Androgens, health and sexuality in women and men.Hypoactive Sexual Desire Disorder and current pharmacotherapeutic options in women.Managing low sexual desire in women.Testosterone supplementation for hypoactive sexual desire disorder in women.The safety of postmenopausal testosterone therapy.The use of hormone therapy for the maintenance of urogynecological and sexual health post WHI.An update on the pharmacological management of female sexual dysfunction.Androgens and cardiovascular disease in postmenopausal women: a systematic review.An update on sexual function and dysfunction in women.New developments in the treatment of hypoactive sexual desire disorder - a focus on Flibanserin.Low dose of methyltestosterone in ovariectomised rats improves baroreflex sensitivity without geno- and cytotoxicity.Effect of androgens combined with hormone therapy on quality of life in post-menopausal women with sexual dysfunction.Preliminary clinical experience with androgen administration for pre- and postmenopausal women with hypoactive sexual desire.Effects of the addition of methyltestosterone to combined hormone therapy with estrogens and progestogens on sexual energy and on orgasm in postmenopausal women.Effects of long-term hormone treatment and of tibolone on monoamines and monoamine metabolites in the brains of ovariectomised, Cynomologous monkeys.Role of androgens in modulating male and female sexual function.The post-menopausal ovary displays a unique pattern of steroidogenic enzyme expression.The contribution of SHBG to the variation in HOMA-IR is not dependent on endogenous oestrogen or androgen levels in postmenopausal women
P2860
Q24245502-2FC9C221-A5F2-458A-AA75-AE6587108320Q24647700-941CA506-2776-4AF8-A99F-4B417012C22CQ26795412-EAAB9864-0A1A-4839-885A-3AFD64B5BBBDQ31164239-B0A4B45A-BF73-4042-BE38-725D52A49408Q34418266-7E93345C-0B92-4C7B-851D-F70FCAD083EAQ35006435-710AF1B4-4B4A-482C-AD2D-6DFCE2D2110FQ35143192-3D6E5F4E-436C-4177-B292-D96D3B637153Q36103483-79CC9A17-AB5E-4EF4-BCE9-427BF09E7C09Q36109827-75DC0C14-132F-4A64-B670-4ACB7E29D12FQ36249910-D2CB3D03-28FF-48D2-967B-7329D0E5C407Q36364326-1675B720-BDB2-4AC9-9C98-BB93FBCF6BC4Q36483817-EE94F50A-77D3-4BD8-9025-06BB1B975899Q36939272-AF0B026F-4458-4F5E-B204-E4A89C32F042Q37060552-05B4F90C-0D20-4207-B20D-2EBA00E63C35Q37196403-F8321994-1F79-431D-A7C0-A8FE0E28E55EQ37608368-021C26FE-EC1C-4B6A-8358-E08F5D4F9F97Q37643712-FD253CE1-51F7-4B6C-9F15-66A5B0A5A792Q37678925-325BEE22-FC3E-456F-8BBA-D733E28AA9B8Q37813672-3157E533-4C6F-4922-9970-DE7CB2519F54Q37822796-8AA62DF3-38BF-4B1D-97A8-5A03A07F9B0FQ37924289-87DAF6D5-AB9E-4277-B538-C3B6D31D32F1Q37990887-432A857B-2A85-475A-B40C-656E8DB86D7AQ38007199-F031366C-912D-4903-9497-3BBA8E04C6EBQ38011784-0B1AD5F2-47F8-4279-B393-33410434127DQ38044019-2D258BA5-4736-4430-85E2-754A32402BF1Q38190104-47128245-DBB4-4AD9-8548-3C0B7AFC7F72Q38454048-36D02D2D-BD6B-486A-A79C-E111F201433EQ39262633-8CAD9A26-137C-4BF5-9A18-410491D50D01Q39792087-D20F4714-03C2-44C5-BC55-642BE06BDFA3Q46145074-33828C8F-63A0-444B-AA81-7A0329B68D83Q46601280-357C273A-BB27-482D-9D13-BDE0472A8DE5Q46802795-AB52D673-A099-4A96-8187-4049FF22660AQ48458795-05373BBB-9C98-4BE6-943B-B1B6AED7CA09Q51530874-56AE421C-4772-4B38-BFDF-032F2D16CA3FQ53651626-DC59B006-4AAB-407A-928A-E4D1DE5FDC79Q57988282-24A67254-A23E-4A7F-84FD-BDB4B97CA21C
P2860
Comparative effects of oral esterified estrogens with and without methyltestosterone on endocrine profiles and dimensions of sexual function in postmenopausal women with hypoactive sexual desire.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh
2003年學術文章
@zh-hant
name
Comparative effects of oral es ...... with hypoactive sexual desire.
@en
Comparative effects of oral es ...... with hypoactive sexual desire.
@nl
type
label
Comparative effects of oral es ...... with hypoactive sexual desire.
@en
Comparative effects of oral es ...... with hypoactive sexual desire.
@nl
prefLabel
Comparative effects of oral es ...... with hypoactive sexual desire.
@en
Comparative effects of oral es ...... with hypoactive sexual desire.
@nl
P2093
P1476
Comparative effects of oral es ...... with hypoactive sexual desire.
@en
P2093
Barbara Block
Hwa Ming Yang
Raymond C Rosen
Rogerio A Lobo
Roland Gerritsen Van Der Hoop
P304
P356
10.1016/S0015-0282(03)00358-3
P407
P577
2003-06-01T00:00:00Z